Suvorexant-Induced Dream Enactment Behavior in...

Suvorexant-Induced Dream Enactment Behavior in Parkinson Disease: A Case Report

Abstract

Suvorexant is a new insomnia drug, and it is generally safe and well tolerated. Here, we report a rare but potentially important adverse effect of suvorexant in a patient with Parkinson disease.Citation:Tabata H, Kuriyama A, Yamao F, Kitaguchi H, Shindo K. Suvorexant-induced dream enactment behavior in Parkinson disease: a case report. J Clin Sleep Med. 2017;13(5):759–760.

Authors

Tabata H; Kuriyama A; Yamao F; Kitaguchi H; Shindo K

Journal

Journal of Clinical Sleep Medicine, Vol. 13, No. 5, pp. 759–760

Publisher

Springer Nature

Publication Date

May 15, 2017

DOI

10.5664/jcsm.6600

ISSN

1550-9389

Associated Experts

Akira Kuriyama

Visiting Associate Professor, Faculty of Health Sciences

Visit profile

Labels

Suvorexant-Induced Dream Enactment Behavior in Parkinson Disease: A Case Report

Abstract

Authors

Journal

Publisher

Publication Date

DOI

ISSN

Associated Experts

Labels

Fields of Research (FoR)

Sustainable Development Goals (SDG)

Medical Subject Headings (MeSH)

Contact the Experts team